comparemela.com

Latest Breaking News On - Elyad oncology sa - Page 1 : comparemela.com

Celyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC Seite 1

15.09.2023 - Regulatory News: Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major . Seite 1

Brussels
Bruxelles-capitale
Belgium
United-kingdom
Paris
France-general
France
Belgian
Company-brussels
Fortress-investment-group
Regulatory-news

Celyad Oncology Reports First Half 2023 Financial Results

Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement.

Belgium
United-states
London
City-of
United-kingdom
Walloon-region
Waals-gewest
Mont-saint-guibert
Boston
Massachusetts
Parc
Region-flamande

Celyad Oncology to announce full year 2022 financial

MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company.

Mont-saint-guibert
Waals-gewest
Belgium
New-york
United-states
David-georges
Caroline-lonez
Exchange-commission
Business-development
Wrd-communications
Belgium-fixed
Belgium-mobile

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.